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Introduction
High-sensitive cardiac troponin (Hs-cTn) is the new
standard cardiac biomarker for the diagnosis of myocar-
dial necrosis [1].
Objectives
We conducted a prospective study to compare the
course and values of the Hs-cTn and CK-MB after
CABG and OPCAB surgery. We also evaluated the rela-
tionship between values > 10 × 99th percentile URL of
CK-MB and Hs-cTn as a possible marker for peri-
operative myocardial infarction.
Methods
After ethics’ committee approval and written informed
consent all adult patients undergoing elective cardiac
surgery between February and November 2014 were
included. Exclusion criteria were urgent surgery, GFR <
60 ml/min/1.73m2), CK-MB > 4 Î¼g/L and/or Hs-cTn
> 14 ng/L at baseline. Hs-cTn and CK-MB were mea-
sured before induction of anaesthesia (baseline), upon
arrival in the ICU and at 3, 6, 9, 12, 18, 24 and 48 hrs
after arrival. ECGâTs were independently reviewed by
two blinded cardiologist. Patients with peri-operative
AMI as defined by the third universal definition of AMI
(10 × 99th percentile of URL for CK-MB) were excluded
for post hoc analysis [2].
Results
Of the 121 patients admissible for inclusion, 63 in the
CABG group and 21 in the OPCAB group met all inclu-
sion criteria in this preliminary data set. CK-MB values
are higher from ICU arrival up to T24 vs. baseline in
both CABG and OPCAB (p < 0.0001) with a peak at T3.
For Hs-cTn, ICU up to T48 values are higher (p < 0.01)
in CABG with a peak at T6, and from T3 to T48 in
OPCAB (p < 0.05) vs. baseline (Figure 1). In 62 CABG
(98.4 %) and 16 OPCAB patients (76.1 %) all individual
Hs-cTn values are above 140 ng/L (= 10 × 99th percen-
tile of URL).
Conclusions
Both CK-MB and Hs-cTn levels increase significantly
after cardiac surgery, and peak later for Hs-cTn than
for CK-MB. Values were higher in CABG vs. OPCAB
patients for both biomarkers. Postoperative Hs-cTn
levels exceed the 10 × 99th percentile of URL in nearly
all CABG patients. Our data show an important discre-
pancy between the 10 × 99th percentile for both bio-
markers, and suggest a different definition for post-
operative myocardial infarction may be needed when
Hs-cTn is used.
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Figure 1 Hs-cTn in CABG vs OPCAB surgery.
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